WO2003047503A3 - Delivery of medicaments to the nail - Google Patents
Delivery of medicaments to the nail Download PDFInfo
- Publication number
- WO2003047503A3 WO2003047503A3 PCT/US2002/033694 US0233694W WO03047503A3 WO 2003047503 A3 WO2003047503 A3 WO 2003047503A3 US 0233694 W US0233694 W US 0233694W WO 03047503 A3 WO03047503 A3 WO 03047503A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nail
- medicament
- present
- compositions
- medicaments
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 5
- 210000000282 nail Anatomy 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 238000005530 etching Methods 0.000 abstract 2
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 210000004905 finger nail Anatomy 0.000 abstract 1
- 210000004904 fingernail bed Anatomy 0.000 abstract 1
- 210000004906 toe nail Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002364893A AU2002364893A1 (en) | 2001-10-22 | 2002-10-22 | Delivery of medicaments to the nail |
CA2468539A CA2468539C (en) | 2001-10-22 | 2002-10-22 | Delivery of medicaments to the nail |
US10/830,730 US7959904B2 (en) | 2001-10-22 | 2004-04-22 | Delivery of medicaments to the nail |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33041501P | 2001-10-22 | 2001-10-22 | |
US60/330,415 | 2001-10-22 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/830,730 Continuation-In-Part US7959904B2 (en) | 2001-10-22 | 2004-04-22 | Delivery of medicaments to the nail |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003047503A2 WO2003047503A2 (en) | 2003-06-12 |
WO2003047503A3 true WO2003047503A3 (en) | 2003-12-18 |
Family
ID=23289669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/033694 WO2003047503A2 (en) | 2001-10-22 | 2002-10-22 | Delivery of medicaments to the nail |
Country Status (4)
Country | Link |
---|---|
US (1) | US7959904B2 (en) |
AU (1) | AU2002364893A1 (en) |
CA (1) | CA2468539C (en) |
WO (1) | WO2003047503A2 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2372113C2 (en) | 2003-07-14 | 2009-11-10 | Пауэр Пэйпер Лтд. | Method, apparatus and kit for onychomycosis treatment with using electrokinetic mass transport |
CA2547990C (en) | 2003-12-08 | 2011-08-02 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for insulin treatment |
US20050256553A1 (en) * | 2004-02-09 | 2005-11-17 | John Strisower | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation |
US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
US7740875B2 (en) * | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
WO2006063350A2 (en) * | 2004-12-10 | 2006-06-15 | Talima Therapeutics, Inc. | Compositions and methods for treating conditions of the nail unit |
US20060275230A1 (en) | 2004-12-10 | 2006-12-07 | Frank Kochinke | Compositions and methods for treating conditions of the nail unit |
US8277495B2 (en) | 2005-01-13 | 2012-10-02 | Candela Corporation | Method and apparatus for treating a diseased nail |
US20090215888A1 (en) * | 2006-03-02 | 2009-08-27 | Singh Jagat | Topical nail formulation |
US20080107735A1 (en) * | 2006-11-02 | 2008-05-08 | Gyurik Robert J | Macrocyclic formulations for transmembrane drug delivery |
WO2008105038A1 (en) * | 2007-02-23 | 2008-09-04 | Nichiban Company Limited | Adhesive patch for mycosis |
US20080261986A1 (en) * | 2007-03-30 | 2008-10-23 | Friden Phillip M | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
US20100291182A1 (en) * | 2009-01-21 | 2010-11-18 | Arsenal Medical, Inc. | Drug-Loaded Fibers |
US20100234925A1 (en) * | 2009-03-16 | 2010-09-16 | PinPoint U.S.A., Inc. | Treatment of microbiological pathogens in a toe nail with antimicrobial light |
GB0907553D0 (en) | 2009-05-01 | 2009-06-10 | Insense Ltd | Treatment of human or animal body surface infection |
US8814922B2 (en) * | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US20110202016A1 (en) * | 2009-08-24 | 2011-08-18 | Arsenal Medical, Inc. | Systems and methods relating to polymer foams |
US9044580B2 (en) | 2009-08-24 | 2015-06-02 | Arsenal Medical, Inc. | In-situ forming foams with outer layer |
US9173817B2 (en) | 2009-08-24 | 2015-11-03 | Arsenal Medical, Inc. | In situ forming hemostatic foam implants |
US10420862B2 (en) | 2009-08-24 | 2019-09-24 | Aresenal AAA, LLC. | In-situ forming foams for treatment of aneurysms |
US20130089629A1 (en) * | 2010-06-07 | 2013-04-11 | Topical Pharma Ab | Kit for the treatment of onychomycosis by nitric oxide |
US8968626B2 (en) | 2011-01-31 | 2015-03-03 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
US9034240B2 (en) | 2011-01-31 | 2015-05-19 | Arsenal Medical, Inc. | Electrospinning process for fiber manufacture |
US9194058B2 (en) | 2011-01-31 | 2015-11-24 | Arsenal Medical, Inc. | Electrospinning process for manufacture of multi-layered structures |
CN104010598B (en) | 2011-09-05 | 2015-12-09 | 库尔诊疗公司 | For causing, the hypothermic pogonip stomach of therapeutic is sent, dermal delivery or peritoneum are sent |
US8993831B2 (en) | 2011-11-01 | 2015-03-31 | Arsenal Medical, Inc. | Foam and delivery system for treatment of postpartum hemorrhage |
EP2968886A1 (en) | 2013-03-14 | 2016-01-20 | Hallux, Inc. | Method of treating infections, diseases or disorders of nail unit |
KR20170027719A (en) | 2014-05-29 | 2017-03-10 | 뉴 스킨 테라피스, 엘엘씨, 디/비/에이/ 엔에스티 컨설팅, 엘엘씨 | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
US11358002B2 (en) | 2014-05-29 | 2022-06-14 | Raymond R. Blanche | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
WO2019135123A1 (en) * | 2018-01-02 | 2019-07-11 | Nal Pharmaceutical Group Limited | Liquid dosage form for topical application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5947956A (en) * | 1997-11-04 | 1999-09-07 | Karell; Manuel Leon | Laser apparatus for making holes and etchings |
US6042845A (en) * | 1994-12-22 | 2000-03-28 | Johnson & Johnson Consumer Products, Inc. | Anti fungal treatment of nails |
US6143794A (en) * | 1998-04-17 | 2000-11-07 | Bertek Pharmaceuticals, Inc. | Topical formulations for the treatment of nail fungal diseases |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4180058A (en) * | 1978-08-15 | 1979-12-25 | Jacob Brem | Method of treating pathological conditions of the nail |
US4637930A (en) | 1984-02-08 | 1987-01-20 | Yamanouchi Pharmaceutical Co, Ltd. | Transdermal formulation of nicardipine hydrochloride |
GB2160419B (en) | 1984-06-08 | 1990-02-14 | Crestol Ltd | Treatment of hair, skin and nails |
KR900700075A (en) | 1988-03-04 | 1990-08-11 | 로트만 존 | Storage-Stable Compositions and Methods for Treatment of Keratin Tissue |
IL97012A0 (en) | 1990-01-30 | 1992-03-29 | Gist Brocades Nv | Topical preparations for treating human nails |
EP0472858B2 (en) | 1990-07-04 | 2000-03-15 | Kao Corporation | Hair treatment composition |
US5487776A (en) * | 1994-03-17 | 1996-01-30 | Nimni; Marcel | Anti-fungal nail lacquer and method therefor |
US5993790A (en) * | 1997-08-04 | 1999-11-30 | Pedinol Pharmacal Inc. | Nail evulsion compositions and method for evulsing nails and treating nail and nail bed infections |
DE69907341T2 (en) * | 1998-02-09 | 2004-01-22 | Macrochem Corp., Lexington | ANTIMYCOTIC NAIL POLISH |
US6264927B1 (en) * | 1998-08-27 | 2001-07-24 | Elmer P. Monahan | Topical solution and method for the treatment of nail fungus |
US6159977A (en) * | 1998-11-16 | 2000-12-12 | Astan, Inc. | Therapeutic anti-fungal nail preparation |
US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
US6413555B1 (en) * | 2000-12-29 | 2002-07-02 | All Nature's Solutions L.L.C. | Composition and method of treating nail infections |
US6664292B2 (en) * | 2001-06-04 | 2003-12-16 | Mark H. Bogart | Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor |
US6846837B2 (en) * | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
-
2002
- 2002-10-22 AU AU2002364893A patent/AU2002364893A1/en not_active Abandoned
- 2002-10-22 WO PCT/US2002/033694 patent/WO2003047503A2/en not_active Application Discontinuation
- 2002-10-22 CA CA2468539A patent/CA2468539C/en not_active Expired - Lifetime
-
2004
- 2004-04-22 US US10/830,730 patent/US7959904B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6042845A (en) * | 1994-12-22 | 2000-03-28 | Johnson & Johnson Consumer Products, Inc. | Anti fungal treatment of nails |
US5947956A (en) * | 1997-11-04 | 1999-09-07 | Karell; Manuel Leon | Laser apparatus for making holes and etchings |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
US6143794A (en) * | 1998-04-17 | 2000-11-07 | Bertek Pharmaceuticals, Inc. | Topical formulations for the treatment of nail fungal diseases |
Also Published As
Publication number | Publication date |
---|---|
AU2002364893A1 (en) | 2003-06-17 |
WO2003047503A2 (en) | 2003-06-12 |
US7959904B2 (en) | 2011-06-14 |
US20040197280A1 (en) | 2004-10-07 |
CA2468539C (en) | 2013-01-08 |
CA2468539A1 (en) | 2003-06-12 |
AU2002364893A8 (en) | 2003-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003047503A3 (en) | Delivery of medicaments to the nail | |
AU2001246484A1 (en) | Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails | |
HUP0300135A3 (en) | Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails | |
WO2004056307A3 (en) | Disease treatment via antimicrobial peptide inhibitors | |
BR9807673A (en) | Processes to treat allergic asthma and dermatitis in a human and pharmaceutical composition. | |
CA2290520A1 (en) | Inhibition of p38 kinase activity by aryl ureas | |
NO20040936D0 (en) | Patches for the treatment of dysfunction and disorders of nail growth. | |
WO2002062763A3 (en) | Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas | |
IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
IL136737A0 (en) | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas | |
IL136738A0 (en) | Inhibition of p38 kinase activity using substituted heterocyclic ureas | |
WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
BR0017212A (en) | Preformed device; production method of the device; and method of transferring at least one cosmetic benefit agent to skin, hair or nails | |
WO2002067967A3 (en) | Method of treating rhinitis or sinusitis | |
NZ531404A (en) | Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole | |
AU1865100A (en) | Hyaluronate lyase used for promoting penetration in topical agents | |
WO2005034883A3 (en) | A method of healing skin wounds in mammals and a composition therefor | |
RS50593B (en) | Containing lozenges used against inflammatory oral and pharyngeal diseases | |
WO2002065989A3 (en) | Aminoglycoside treatment for lysosomal storage diseases | |
WO2002064160A8 (en) | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof | |
MXPA03011622A (en) | Use of glycoprotein for the treatment and re-epithelialisation of wounds. | |
BR0307022A (en) | Method of treating a patient who needs analgesia | |
WO2000061125A3 (en) | Osanetant in the treatment of mood disorders | |
WO2002100317A3 (en) | Targeted particles and methods of using the same | |
WO2001089530A3 (en) | Combination therapy for treatment of depression comprising an antidepressant and an ampa receptor potentiator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10830730 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2468539 Country of ref document: CA |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |